— Series B fundraise led by Deerfield Management enables scaling of pivotal clinical trial and commercial readiness activities for Reprieve® System – First patient enrolled in FASTR II study by Washington University School of Medicine in St. Louis MILFORD, Mass., August 13, 2025 – Reprieve Cardiovascular, Inc., a clinical-stage company pioneering intelligent decongestion management therapy for […]
SAN FRANCISCO, May 7, 2025 /PRNewswire/ — Carta Healthcare, a leading provider of AI-powered clinical data abstraction, today announced it has secured $18.25 million in Series B1 financing. This investment will accelerate the company’s growth as demand surges among health systems and life sciences organizations for AI-driven innovation that transforms clinical data into valuable insights. The investment was led by […]
DURHAM, N.C., March 17, 2025 — 410 Medical, Inc., a medical device company focused on innovative technologies for emergency and critical care, today announced the completion of a $14 million Series B financing. Existing investor Hatteras Venture Partners led the funding round with participation from Orlando Health Ventures, Ballad Ventures, OSF Healthcare, WakeMed, Rex Health Ventures, […]
